Fundamental Valuation Report Personalis(PSNL:NAS) Healthcare:Diagnostics & Research This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$18.57 (USD) 05/12/2021 Weighted Valuation$29.48 (USD) Overall RatingUndervalued by 58.7% Valuation Models Comparables: $30.64 (USD) Multiples: $27.74 …

Personalis (PSNL:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report NeoGenomics(NEO:NAS) Healthcare:Diagnostics & Research This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$41.09 (USD) 05/07/2021 Weighted Valuation$40.17 (USD) Overall RatingFairly valued to slightly Overvalued by 2.2% Valuation Models …

NeoGenomics (NEO:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Lantheus Holdings(LNTH:NAS) Healthcare:Diagnostics & Research This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$22.34 (USD) 05/05/2021 Weighted Valuation$22.46 (USD) Overall RatingFairly valued to slightly Undervalued by 0.6% Valuation …

Lantheus Holdings (LNTH:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Fluidigm(FLDM:NAS) Healthcare:Diagnostics & Research This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$4.94 (USD) 04/28/2021 Weighted Valuation$7.08 (USD) Overall RatingUndervalued by 43.4% Valuation Models Multiples: $4.84 (USD) Adjusted …

Fluidigm (FLDM:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Pacific Biosciences(PACB:NAS) Healthcare:Diagnostics & Research This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$29.95 (USD) 03/30/2021 Weighted Valuation$29.15 (USD) Overall RatingFairly valued to slightly Overvalued by 2.7% Valuation …

Pacific Biosciences (PACB:NAS) Fundamental Valuation Report Read more »

Read More

Stockcalc – Free Trial Have a free look inside the StockCalc website at www.stockcalc.com I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available …

Cheniere Energy Partners (CQP:ASE) and Senseonics Holdings (SENS:ASE) Are Fully Valued Read more »

Read More

Stockcalc – Free Trial Have a free look inside the StockCalc website at www.stockcalc.com I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available …

Cheniere Energy Partners (CQP:ASE) and Senseonics Holdings (SENS:ASE) Are Fully Valued Read more »

Read More

Stockcalc – Free Trial Have a free look inside the StockCalc website at www.stockcalc.com I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available …

Cheniere Energy Partners (CQP:ASE) and Senseonics Holdings (SENS:ASE) Are Fully Valued Read more »

Read More

Stockcalc – Free Trial Have a free look inside the StockCalc website at www.stockcalc.com I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available …

Cheniere Energy Partners (CQP:ASE) and Senseonics Holdings (SENS:ASE) Are Fully Valued Read more »

Read More

Stockcalc – Free Trial Have a free look inside the StockCalc website at www.stockcalc.com I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available …

Cheniere Energy Partners (CQP:ASE) and Senseonics Holdings (SENS:ASE) Are Fully Valued Read more »

Read More